Avita Medical
RCEL
31 hedge funds and large institutions have $52.9M invested in Avita Medical in 2019 Q4 according to their latest regulatory filings, with 31 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
23.3% more ownership
Funds ownership: 0% → 23.3% (+23%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Blackcrane Capital
Bellevue,
Washington
|
+$45.6M |
| 2 |
Morgan Stanley
New York
|
+$671K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$354K |
| 4 |
MA
MCF Advisors
Covington,
Kentucky
|
+$166K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$143K |
Top Sellers
RCEL Hedge Fund Activity: Q4 2019 in Review
31 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q4 2019, worth a combined $52.9M.
Buyers outnumbered sellers: 31 funds opened new RCEL positions and 0 closed out — a net gain of 31 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Blackcrane Capital, opening a new position worth an estimated $45.6M.
- 31 institutional investors held Avita Medical (RCEL) as of Q4 2019, up from 0 in Q3 2019.
- Funds reported $52.9M of Avita Medical stock for Q4 2019.
- 31 funds opened new Avita Medical positions in Q4 2019 and 0 closed out, a net change of +31 holders.
- The largest Avita Medical buyer in Q4 2019 was Blackcrane Capital, an estimated $45.6M added.
Based on aggregated 13F filings for Q4 2019.